Medicamen Biotech informs about disclosures

23 Mar 2024 Evaluate
Medicamen Biotech has enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received from Growel Remedies sale of 2,00,000 equity shares.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

302.30 -15.10 (-4.76%)
23-Feb-2026 15:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1733.75
Dr. Reddys Lab 1303.95
Cipla 1326.10
Zydus Lifesciences 908.85
Lupin 2250.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×